We are looking for children and teenagers 2–17 years of age to join a research study to help us discover more about treating moderate to severe UC. If you are looking for a potential new treatment option for moderate to severe UC or Inflammatory bowel disease (including associated symptoms such as chronic diarrhea, inflammation of the bowel or intestine, bloody stool, frequent fevers and/or anemia), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the IBD clinical trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child is eligible.
